2m 2m 2m 2m 2m 2m 2m
Annovis Bio (ANVS)
NYSE
$0.98-$0.01 (-1.18%)
Price as of Oct 23, 2026 1:06 PM EDT- $42.3MMarket Cap
- -50.91%1-Year Change
- BiotechnologyIndustry
Annovis Bio (ANVS)
$0.98-$0.01 (-1.18%)
ANVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | -$0.001 (-0.15%) | ||
Open | $0.99 | ||
High | $1.05 | ||
Low | $0.98 | ||
Previous Close | $0.99 | ||
Volume | 448,442 | ||
30-Day Average Volume | 734,871 | ||
1-Week Change | -5.55% | ||
1-Month Change | -21.29% | ||
1-Year Change | -50.91% | ||
3-Year Change | -88.44% | ||
5-Year Change | -96.57% | ||
Fundamentals | |||
Shares Outstanding | 42.7M | ||
Total Assets | $22.0M | ||
Market Cap | $42.3M | ||
Enterprise Value | $23.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.8M | ||
Free Cash Flow | -$21.9M | ||
EBIT | -$14.8M | ||
EBITDA | -$14.8M | ||
Net Working Capital | $12.4M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -10 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue